Philips and Leading Network of Healthcare Centers and Clinics in Russia to Modernize the Country's Regional Healthcare Infrastructures

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) today announced the signing of a 10-year strategic partnership agreement with the Expert Group of Companies, one of Russia's leading network of healthcare centers and clinics, to jointly improve the efficiency of the delivery of patient care in Russia. As part of the multi-year agreement, which has a total value of approximately EUR 74 million, Philips will equip the Group's new clinics with healthcare solutions for high-quality diagnosis and treatment.

Innovative MRI and CT scanners, advanced ultrasound and angiography systems combined with integrated clinical informatics solutions will optimize clinical processes, improve workflows and reduce costs. As the technology partner, Philips will also provide its deep clinical expertise, consulting services and technology planning for multidisciplinary medical centers and specialized cardiac centers. Furthermore, Philips and the Expert Group of Companies have plans to develop joint educational initiatives in the areas of MRI, ultrasound and endovascular diagnostics.

"The strategic partnership agreement with Philips, a global leader in health technology, will make innovative solutions for diagnosis and treatment available to more patients in Russia," said Elena Latysheva, President of the Expert Group of Companies. "The Expert Group of Companies has ten years of experience in the medical industry in Russia. The integrated approach and advanced technologies for diagnostics and treatment that will be available in our centers will improve the standards of medical care. We are confident that the partnership with Philips will help us achieve our strategic goal to become one of the largest private healthcare networks in Russia by 2026."

"This long-term cooperation with the Expert Group of Companies furthers our mission to improve people's lives across the health continuum - from healthy lifestyle, disease prevention and early diagnosis to treatment and home care," said Arman Voskerchyan, CEO of Philips Russia and Central Asia. "We firmly believe that this cooperation will improve patient outcomes and help to develop high-tech medical care in Russia."

The partnership will aim to improve the provision of medical services in existing Expert diagnostic centers across the country as well as establishing new hospitals and developing new business models. The Expert Group of companies also considers joining public-private partnerships in the field of public health. It represents a new format of cooperation, bringing together consultancy for business development and providing innovative medical equipment for clinics. The Expert Group of Companies and Philips plan to jointly develop a long-term strategy and transformation program for existing Expert centers. Moreover, the companies will focus on the development of a regional network of 35 multidisciplinary medical centers to expand the range and scope of service provision.

Cardiovascular disease is one of the major challenges for Russia's healthcare system. The collaboration aims to develop and implement integrated programs for cardiology ranging from prevention and diagnosis, to treatment and home care. The partners will address doctors' training and the introduction of new therapy methods into clinical practice.

The Expert Group of Companies aims to focus on the development of cooperation models between governmental and private medical institutions in the field of endovascular diagnostics and treatment across Russia. Pilot public-private partnership projects will be implemented in the Russian regions of Lipetsk, Voronezh and Yaroslavl, which are collectively home to more than five million people.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The Company leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the Company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. The Company's health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 70,000 employees with sales and services in more than 100 countries.

Most Popular Now

Researchers Invent AI Model to Design Ne…

Researchers at McMaster University and Stanford University have invented a new generative artificial intelligence (AI) model which can design billions of new antibiotic molecules that are inexpensive and easy to...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Greater Manchester Reaches New Milestone…

Radiologists and radiographers at Northern Care Alliance NHS Foundation Trust have become the first in Greater Manchester to use the Sectra picture archiving and communication system (PACS) to report on...

Powerful New AI can Predict People'…

A powerful new tool in artificial intelligence is able to predict whether someone is willing to be vaccinated against COVID-19. The predictive system uses a small set of data from demographics...

AI-Based App can Help Physicians Find Sk…

A mobile app that uses artificial intelligence, AI, to analyse images of suspected skin lesions can diagnose melanoma with very high precision. This is shown in a study led from...

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...